Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

aTYR PHARMA (ATYR) Revenue (2019 - 2025)

aTYR PHARMA's Revenue history spans 6 years, with the latest figure at $190000.0 for Q3 2025.

  • For Q3 2025, Revenue changed N/A year-over-year to $190000.0; the TTM value through Dec 2025 reached $190000.0, down 19.15%, while the annual FY2025 figure was $190000.0, 19.15% down from the prior year.
  • Revenue reached $190000.0 in Q3 2025 per ATYR's latest filing, down from $235000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $10.4 million in Q4 2022 to a low of $190000.0 in Q3 2025.
  • Average Revenue over 4 years is $2.8 million, with a median of $294000.0 recorded in 2023.